Condition
Locally Advanced, Recurrent or Metastatic Malignancies clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Locally Advanced, Recurrent or Metastatic Malignancies clinical trials that are recruiting, in China. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
SSGJ-705 alone and with chemotherapy for advanced HER2-positive cancers
This trial tests whether SSGJ-705, by itself or combined with chemotherapy (and in some arms with a PD‑1/L1 blocker), can help adults with advanced HER2-positive lung, breast, or stomach cancers.
-
Evaluating SSGJ-705 for advanced malignant tumors
This study is testing a new treatment called SSGJ-705 to see if it is safe and effective for people with advanced cancer.
Quick answers
How many Locally Advanced, Recurrent or Metastatic Malignancies clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.